NEA Management Company, LLC - SUNESIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$258,000
+59.3%
129,8270.0%0.01%0.0%
Q3 2020$162,000
-52.6%
129,827
-90.0%
0.01%
-50.0%
Q2 2020$342,000
-36.5%
1,298,2740.0%0.01%
-50.0%
Q1 2020$539,000
+23.1%
1,298,2740.0%0.03%
+33.3%
Q4 2019$438,000
-53.2%
1,298,2740.0%0.02%
-72.7%
Q3 2019$935,000
-0.8%
1,298,2740.0%0.08%
+16.7%
Q2 2019$943,000
-40.5%
1,298,2740.0%0.07%
-19.5%
Q1 2019$1,584,000
+193.9%
1,298,2740.0%0.08%
+290.5%
Q4 2018$539,000
-79.2%
1,298,2740.0%0.02%
-81.2%
Q3 2018$2,597,000
-5.6%
1,298,2740.0%0.11%
-13.2%
Q2 2018$2,752,000
-22.1%
1,298,2740.0%0.13%
-17.8%
Q1 2018$3,531,000
-26.3%
1,298,2740.0%0.16%
-20.7%
Q4 2017$4,791,000
+90.2%
1,298,2740.0%0.20%
+125.0%
Q3 2017$2,519,000
-28.1%
1,298,2740.0%0.09%
-31.2%
Q2 2017$3,505,000
-34.2%
1,298,2740.0%0.13%
-30.8%
Q1 2017$5,323,000
+13.3%
1,298,2740.0%0.18%
-1.1%
Q4 2016$4,700,000
-17.2%
1,298,2740.0%0.19%
-26.7%
Q3 2016$5,673,0001,298,2740.26%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 7,600,000$9,234,0007.03%
Samsara BioCapital, LLC 3,750,000$4,556,0003.58%
CAXTON CORP 277,245$337,0000.31%
BVF INC/IL 2,287,860$2,780,0000.31%
Eventide Asset Management 5,965,455$7,248,0000.25%
Telemetry Investments, L.L.C. 197,564$240,0000.12%
NEA Management Company, LLC 1,298,274$1,584,0000.08%
RP Management, LLC 129,517$158,0000.08%
Palo Alto Investors LP 1,162,473$1,412,0000.06%
Fosun International Ltd 725,000$863,0000.06%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders